Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02454192 · ClinicalTrials.gov registry record · NA
Community Healthcare for Asthma Management and Prevention of Symptoms
A NA study, sponsored by George Washington University.
- Completed
- Registry status
- NA
- Development phase
- 599
- Enrollment target
NCT02454192: Completed NA study, sponsored by George Washington University.
NCT02454192 is a NA study that has completed, run by George Washington University. The registered enrollment target is 599 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02454192, a NA study, has completed, sponsored by George Washington University.
- COMPLETED
- Registry status
- NA
- Development phase
- 599 participants
- Enrollment target
Study Summary
The purpose of this study is to systematically investigate across health center study sites participating in this study the process of adopting, integrating, implementing, and diffusing a minimum set of evidence-based interventions for the management of childhood asthma. Investigators hypothesized that an intervention that is evidence- and consensus-based (i.e., minimum elements to be integrated into existing practice, dosing of each element) would be implemented effectively, as measured by health center performance improvement on child health outcomes, health care utilization, and other measures (e.g., avoidable costs).
Primary Outcome
Reduction in asthma symptom days in the past 4 weeks as measured by the Asthma Symptoms and Utilization (ASU) questionnaire
Interventions
- BEHAVIORAL CHAMPS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 599 participants |
| Start Date | 2010-10 |
| Est. Completion | 2016-03 |
| Phase | NA |
What the finished NCT02454192 record still lists
NCT02454192 is an interventional study that assigns participants to a tested intervention. The registered 599 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (57% lower).
The record links to 0 conditions, and to 1 intervention - of which CHAMPS is the first listed.
NCT02454192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02454192 about?
NCT02454192 is a clinical study titled "Community Healthcare for Asthma Management and Prevention of Symptoms". The purpose of this study is to systematically investigate across health center study sites participating in this study the process of adopting, integrating, implementing, and diffusing a minimum set of evidence-based interventions for the management of childhood asthma. Investigators hypothesized t...
What is the current status of trial NCT02454192?
This trial is currently completed. It is a NA study. The enrollment target is 599 participants. The study started on 2010-10. Estimated completion is 2016-03.
What interventions are being tested in trial NCT02454192?
The interventions under investigation include: CHAMPS (BEHAVIORAL).
Who is sponsoring clinical trial NCT02454192?
This trial is sponsored by George Washington University, which has 133 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02454192's enrollment target sits among peer trials
599 174th of 2000 higher than 1,827 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06875973 · 599 participants · Phase 3
Pelacarsen Roll-over Extension Program
- NCT00004317 · 600 participants · Phase 4
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
- NCT00209235 · 600 participants · NA
Albright Hereditary Osteodystrophy: Natural History, Growth, and Cognitive/Behavioral Assessments
- NCT01473784 · 600 participants · NA
Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia